好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

TNF Receptor-associated Periodic Syndrome Presenting with Polyneuropathy and CNS Demyelination
Autoimmune Neurology
P11 - Poster Session 11 (5:30 PM-6:30 PM)
14-011
NA

TNF receptor-associated periodic syndrome (TRAPS) is an autosomal dominant condition manifesting as periodic exacerbations of systemic inflammation. It is exceedingly rare, with a prevalence of approximately one per one million. Here we report a patient with TRAPS that developed an otherwise unexplained sensory-predominant polyneuropathy and a CNS demyelinating disease that radiographically mimicked multiple sclerosis (MS).

NA
A 74 year old female with a history of TRAPS (with a classic TNFRSF1A mutation on chromosome 12) presented for autonomic evaluation due to complaints of postural lightheadedness. She had decades of episodic fevers, malaise, and rashes. She had developed bilateral foot numbness a few years prior, with EMG/NCS proven sensory neuropathy. A prior tilt table test suggested delayed orthostatic hypotension, without compensatory tachycardia. Prior MRI brain showed multifocal white matter hyperintensities in a pattern consistent with demyelinating disease, and C-spine MRI showed patchy areas of T2 signal hyperintensity. LP was normal, with 0 unique CSF oligoclonal bands. She never had clinical symptoms of an MS attack. Autonomic testing showed normal vasomotor function, length-dependent sudomotor dysfunction, and normal orthostatic vital signs. Repeat EMG/NCS showed slight progression of sensory-predominant axonal polyneuropathy. Work-up for amyloidosis including serology and skin and fat pad biopsy were negative. Neurologic exam showed sensory ataxia, with a positive Romberg sign (during which her “lightheadedness” was reproduced) and diminished large-fiber sensation. It was concluded that she had both sensory neuropathy and dorsal column dysfunction from her intrinsic cervical demyelinating lesion. Canakinumab was initiated for treatment. 
TRAPS is a rare, multisystem inflammatory condition that can produce CNS white matter lesions that can radiographically mimic multiple sclerosis. In addition, TRAPS may be associated with a peripheral polyneuropathy, though further research is warranted.
Authors/Disclosures
Nishika Karbhari, MD (Dartmouth-Hitchcock)
PRESENTER
Dr. Karbhari has nothing to disclose.
Nathaniel M. Robbins, MD (MGB) Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for Red Nucleus. Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for TDG Health. Dr. Robbins has received personal compensation in the range of $0-$499 for serving as a Consultant for Jupiter Life Science Consulting. Dr. Robbins has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Vaccine Injury Compensation Program. The institution of Dr. Robbins has received research support from Diamond Endowment Fund. The institution of Dr. Robbins has received research support from Reeves Endowment Fund. The institution of Dr. Robbins has received research support from Institute for Ethnomedicine. The institution of Dr. Robbins has received research support from Theravance. The institution of Dr. Robbins has received research support from Dysautonomia International. The institution of Dr. Robbins has received research support from National Institute of Health. The institution of Dr. Robbins has received research support from Vertex pharmaceutical. Dr. Robbins has received personal compensation in the range of $50,000-$99,999 for serving as a Locums neurohospitalist with Hayes Locums. Dr. Robbins has received personal compensation in the range of $500-$4,999 for serving as a Speaker with The Dysautonomia Project.